Latest Regulatory Approvals News

Artrya Limited has converted three US foundation partners into commercial customers, generating its first fee-per-scan revenues, while progressing FDA clearance for its Salix Coronary Flow module and expanding its clinical study network.

Medallion Metals has completed a pivotal feasibility study for its Ravensthorpe Gold Project and raised $60 million to accelerate development, while progressing a key acquisition of Forrestania assets.

Peninsula Energy reports strong progress at its Lance Uranium Project in Wyoming, with key production milestones reached and the company on track to meet 2026 uranium output targets amid a buoyant market.

OncoSil Medical has reported a record quarter for dose sales alongside key European market entries and a successful manufacturing milestone, signalling growing momentum for its pancreatic cancer treatment.

CuFe Ltd has raised $5.4 million through a strategic placement and upgraded its Tennant Creek resource to include valuable critical minerals, setting the stage for a major drilling campaign.

Imugene Limited has reported compelling clinical trial results for its off-the-shelf CAR T therapy, azer-cel, alongside FDA validation and a strategic collaboration, while managing cash flow amid cost reductions.

Kingsland Minerals has completed a pivotal scoping study for its Leliyn Graphite Project, confirming high-grade purified spherical graphite production potential. The company also secured $2.16 million through a placement and share purchase plan and has commenced a pre-feasibility study.

Terragen Holdings reports a strong quarter with an 87% increase in sales of its ruminant probiotic and advances key livestock and crop trials, positioning itself for expanded market access.

AKORA Resources has completed a significant trenching program at its Bekisopa iron ore project in Madagascar and submitted a mining permit application under a revitalised regulatory framework, gaining strong government backing.

TerraCom Limited reported a stable operational quarter despite logistical challenges impacting coal shipments and cash flow, while successfully raising A$60 million to bolster liquidity. The Blair Athol mine life was extended to 2033, underpinning the company’s long-term outlook.

The Star Entertainment Group reported a 6% revenue increase to $301 million and a return to EBITDA profit in Q2 FY26, driven by stable Sydney trading, seasonal Gold Coast strength, and a key Brisbane operator fee. Strategic investments and refinancing efforts mark a pivotal phase for the company.

Evergold Minerals Limited advances its gold exploration with new tenement acquisitions and drilling approvals at key projects, while managing a tighter cash position heading into 2026.